Updated following clarification received from the Department of Health that the demonstration of bioequivalence is not required by the Health (Pricing and Supply of Medical Goods) Act 2013.
View tracked changesDetails of ongoing and completed consultations, and resulting updates to the list of interchangeable medicines, are provided below:
Ongoing Consultations
The HPRA cannot comment or provide any further information on specific consultations.
The consultation process with the relevant marketing authorisation holders has commenced for the following active substances:
- Naproxen/Esomeprazole
- Tamsulosin
- Atorvastatin
- Doxycycline
- Ipratropium bromide
- Nitrofurantoin
- Mebeverine hydrochloride
- Phenoxymethylpenicillin
- Enalapril/Lercanidipine
- Enalapril
- Linezolid
- Rivaroxaban
- Amlodipine
- Perindopril
- Acetylsalicylic acid
The active substance will be included in the list, at a mutually agreed time, when the consultation is complete.
Completed Consultations
The consultation process with the relevant marketing authorisation holders has been completed for each of the following active substances (most recently concluded first). The current version of the list includes all these active substances.
2025:
Teriflunomide
Fingolimod
Dabigatran
Imatinib
Dasatinib
Bosutinib
Ranolazine
Dimethyl fumarate
2024:
Tapentadol
Azelastine/Fluticasone
Amoxicillin
Montelukast
Ezetimibe/Atorvastatin
Eplerenone
Esomeprazole
Losartan/Hydrochlorothiazide
Rosuvastatin
Valsartan
Alprazolam
Pomalidomide
Paliperidone
Alendronic acid/Cholecalciferol
Pirfenidone
Atorvastatin
Mirtazapine
Risperidone
Sitagliptin/Metformin
Quetiapine
Trazodone
Solifenacin succinate/Tamsulosin
Bisoprolol
Midodrine
Lercanidipine
Zopiclone
Isotretinoin
Irbesartan/Hydrochlorothiazide
Irbesartan
Rivastigmine
Desloratadine
Ulipristal
Celecoxib
Pramipexole
Fluconazole
Terbinafine
Icatibant
Sunitinib
Voriconazole
Ivabradine
Allopurinol
Ibandronic acid
Exemestane
Sumatriptan
Dutasteride
Salmeterol/Fluticasone
Modafinil
Fesoterodine
Bicalutamide
Apixaban
Sildenafil
Agomelatine
Ipratropium bromide/salbutamol
Escitalopram
Zolpidem
Cinacalcet
Deferasirox
Valaciclovir
Sitagliptin
Fulvestrant